Exact Mass: 304.1827054

Exact Mass Matches: 304.1827054

Found 100 metabolites which its exact mass value is equals to given mass value 304.1827054, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

8-Cyclopentyl-1,3-dipropylxanthine

8-cyclopentyl-1,3-dipropyl-2,3,6,9-tetrahydro-1H-purine-2,6-dione

C16H24N4O2 (304.18991639999996)


D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists DPCPX (PD 116948), a xanthine derivative, is a highly potent and selective Adenosine A1 receptor antagonist, with a Ki of 0.46 nM in 3H-CHA binding to A1 receptors in rat whole brain membranes[1][2][3].

   

NCIOpen2_007467

16beta-Fluoroandrost-4-ene-3,17-dione

C19H25FO2 (304.1838482)


   
   

16alpha-Fluoroandrost-4-ene-3,17-dione

16alpha-Fluoroandrost-4-ene-3,17-dione

C19H25FO2 (304.1838482)


   

3-Methyladipoylcarnitine

3-Methyladipoylcarnitine

C14H26NO6 (304.1760036)


3-Methyladipoylcarnitine is an acylcarnitine. More specifically, it is an 3-methylhexanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy.  This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-Methyladipoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-methyladipoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). 3-Methyladipoylcarnitine has been identified in blood and urine (PMID: 31396400 ). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Tilisolol

4-[3-(tert-butylamino)-2-hydroxypropoxy]-2-methyl-1,2-dihydroisoquinolin-1-one

C17H24N2O3 (304.17868339999995)


   
   

Callyspongenol C

Callyspongenol C

C22H24O (304.1827054)


   
   

3,9-Bis(1,1-dimethyl-2-hydroxyethyl)-2,4,8,10-tetraoxaspiro[5.5]undecane

3,9-Bis(1,1-dimethyl-2-hydroxyethyl)-2,4,8,10-tetraoxaspiro[5.5]undecane

C15H28O6 (304.1885788)


   

Siphonochalynol

Siphonochalynol

C22H24O (304.1827054)


   

(1alpha,4beta,5beta,6beta,7beta,9alpha,10alpha)-1,4,6,9,15-Eudesmanepentol

(1alpha,4beta,5beta,6beta,7beta,9alpha,10alpha)-1,4,6,9,15-Eudesmanepentol

C15H28O6 (304.1885788)


   

geranilan-9-carboxyl-alpha-L-arabinopyranoside

geranilan-9-carboxyl-alpha-L-arabinopyranoside

C15H28O6 (304.1885788)


   

(Z)-docos-19-ene-2,9,11,13,21-pentayn-1-ol|Siphonochalynol

(Z)-docos-19-ene-2,9,11,13,21-pentayn-1-ol|Siphonochalynol

C22H24O (304.1827054)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

FOH 22:11

(4Z,13Z,19Z)-docosadtren-2,9,11,21-tetrayne-1-ol

C22H24O (304.1827054)


   

FAL 22:10

(2E,4E,6E,8E,10E,12E,14E,16E,18E,20E)-docosa-2,4,6,8,10,12,14,16,18,20-decaenal

C22H24O (304.1827054)


   

ascr#10

8R-(3R,5R-dihydroxy-6S-methyl-(2H)-tetrahydropyran-2-yloxy)-nonanoic acid

C15H28O6 (304.1885788)


An (omega-1)-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of (8R)-8-hydroxynonanoic acid with ascarylopyranose (the alpha anomer). A metabolite of the nematode Caenorhabditis elegans, it is the direct biosynthetic precursor to ascr#3. It has also been detected in the sour paste nematode, Panagrellus redivivus.

   

oscr#10

9-(3R,5R-dihydroxy-6S-methyl-(2H)-tetrahydropyran-2-yloxy)-nonanoic acid

C15H28O6 (304.1885788)


An omega-hydroxy fatty acid ascaroside obtained by formal condensation of the alcoholic hydroxy group of 9-hydroxynonanoic acid with ascarylopyranose (the alpha anomer). It is a metabolite of the nematode Caenorhabditis elegans.

   

2-ETHYLHEXYL α-CYANO-4-(3-METHYLOXAZOLIN-2-YLIDENE)CROTONATE

2-ETHYLHEXYL α-CYANO-4-(3-METHYLOXAZOLIN-2-YLIDENE)CROTONATE

C17H24N2O3 (304.17868339999995)


   

L-Arginine mono(4-methyl-2-oxovalerate)

L-Arginine mono(4-methyl-2-oxovalerate)

C12H24N4O5 (304.1746614)


   

ISOPROPYL 3-METHYL-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZOATE

ISOPROPYL 3-METHYL-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZOATE

C17H25BO4 (304.18458000000004)


   

methyl 4-(3-piperidin-1-ylpropylcarbamoyl)benzoate

methyl 4-(3-piperidin-1-ylpropylcarbamoyl)benzoate

C17H24N2O3 (304.17868339999995)


   

(R)-tert-Butyl 4-benzyl-2-formylpiperazine-1-carboxylate

(R)-tert-Butyl 4-benzyl-2-formylpiperazine-1-carboxylate

C17H24N2O3 (304.17868339999995)


   

2-hexyldecylbromide

2-hexyldecylbromide

C16H33Br (304.1765478)


   

4-[2-(HydroxyMethyl)-1H-benzoimidazol-1-yl]butyl Pivalate

4-[2-(HydroxyMethyl)-1H-benzoimidazol-1-yl]butyl Pivalate

C17H24N2O3 (304.17868339999995)


   

Tilisolol

Tilisolol

C17H24N2O3 (304.17868339999995)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents

   

2-(1,3-Dioxolan-2-yl)-1-phenylethylboronic acid pinacol ester

2-(1,3-Dioxolan-2-yl)-1-phenylethylboronic acid pinacol ester

C17H25BO4 (304.18458000000004)


   

Boronic acid, [1-[(1,1-dimethylethyl)dimethylsilyl]-1H-pyrrolo[2,3-b]pyridin-5-yl]-, dimethyl ester (9CI)

Boronic acid, [1-[(1,1-dimethylethyl)dimethylsilyl]-1H-pyrrolo[2,3-b]pyridin-5-yl]-, dimethyl ester (9CI)

C15H25BN2O2Si (304.177826)


   

4,4,5,5-TETRAMETHYL-2-(4-((TETRAHYDRO-2H-PYRAN-2-YL)OXY)PHENYL)-1,3,2-DIOXABOROLANE

4,4,5,5-TETRAMETHYL-2-(4-((TETRAHYDRO-2H-PYRAN-2-YL)OXY)PHENYL)-1,3,2-DIOXABOROLANE

C17H25BO4 (304.18458000000004)


   

1-methyl-4-[1-(4-nitrophenyl)piperidin-4-yl]piperazine

1-methyl-4-[1-(4-nitrophenyl)piperidin-4-yl]piperazine

C16H24N4O2 (304.18991639999996)


   

Ethyl 3-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]propanoate

Ethyl 3-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]propanoate

C17H25BO4 (304.18458000000004)


   

4-(tert-Butoxycarbonyl)phenylboronic acid pinacol ester

4-(tert-Butoxycarbonyl)phenylboronic acid pinacol ester

C17H25BO4 (304.18458000000004)


   

TERT-BUTYL 4-(4-FORMYLBENZYL)PIPERAZINE-1-CARBOXYLATE

TERT-BUTYL 4-(4-FORMYLBENZYL)PIPERAZINE-1-CARBOXYLATE

C17H24N2O3 (304.17868339999995)


   

TERT-BUTYL BENZYLOXY(4-CYANOBUTYL)CARBAMATE

TERT-BUTYL BENZYLOXY(4-CYANOBUTYL)CARBAMATE

C17H24N2O3 (304.17868339999995)


   

tert-butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate

tert-butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate

C17H25BO4 (304.18458000000004)


   

4,4,5,5-TETRAMETHYL-2-(3-((TETRAHYDRO-2H-PYRAN-2-YL)OXY)PHENYL)-1,3,2-DIOXABOROLANE

4,4,5,5-TETRAMETHYL-2-(3-((TETRAHYDRO-2H-PYRAN-2-YL)OXY)PHENYL)-1,3,2-DIOXABOROLANE

C17H25BO4 (304.18458000000004)


   

3-(tert-Butoxycarbonyl)phenylboronic acid pinacol ester

3-(tert-Butoxycarbonyl)phenylboronic acid pinacol ester

C17H25BO4 (304.18458000000004)


   

Tracazolate

ethyl 4-(butylamino)-1-ethyl-6-methylpyrazolo[3,4-b]pyridine-5-carboxylate

C16H24N4O2 (304.18991639999996)


C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   

(S)-1-Boc-4-benzylpiperazine-2-carbaldehyde

(S)-1-Boc-4-benzylpiperazine-2-carbaldehyde

C17H24N2O3 (304.17868339999995)


   

TERT-BUTYL 4-(3-FORMYLBENZYL)PIPERAZINE-1-CARBOXYLATE

TERT-BUTYL 4-(3-FORMYLBENZYL)PIPERAZINE-1-CARBOXYLATE

C17H24N2O3 (304.17868339999995)


   

2,2-(2,4,8,10-TETRAOXASPIRO[5.5]UNDECANE-3,9-DIYL)BIS(2-METHYLPROPAN-1-OL)

2,2-(2,4,8,10-TETRAOXASPIRO[5.5]UNDECANE-3,9-DIYL)BIS(2-METHYLPROPAN-1-OL)

C15H28O6 (304.1885788)


   

1-Bromohexadecane

1-Bromohexadecane

C16H33Br (304.1765478)


   

1-BOC-4-(4-CARBAMIMIDOYL-PHENYL)-PIPERAZINE

1-BOC-4-(4-CARBAMIMIDOYL-PHENYL)-PIPERAZINE

C16H24N4O2 (304.18991639999996)


   

2-BENZYLAMINO-N-CYCLOHEXYL-SUCCINAMIC ACID

2-BENZYLAMINO-N-CYCLOHEXYL-SUCCINAMIC ACID

C17H24N2O3 (304.17868339999995)


   

Methylatropine

Methylatropine

C18H26NO3+ (304.19125859999997)


A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03B - Belladonna and derivatives, plain > A03BB - Belladonna alkaloids, semisynthetic, quaternary ammonium compounds D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics

   

9-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]nonanoic acid

9-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]nonanoic acid

C15H28O6 (304.1885788)


   

(8R)-8-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]nonanoic acid

(8R)-8-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]nonanoic acid

C15H28O6 (304.1885788)


   
   

Androst-4-ene-3,17-dione, 16beta-fluoro-

Androst-4-ene-3,17-dione, 16beta-fluoro-

C19H25FO2 (304.1838482)


   
   

(3-endo)-3-[(2S)-3-Hydroxy-1-oxo-2-phenylpropoxy]-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane

(3-endo)-3-[(2S)-3-Hydroxy-1-oxo-2-phenylpropoxy]-8,8-dimethyl-8-azoniabicyclo[3.2.1]octane

C18H26NO3+ (304.19125859999997)


   

2-Acetylamino-4-methyl-pentanoic acid (1-formyl-2-phenyl-ethyl)-amide

2-Acetylamino-4-methyl-pentanoic acid (1-formyl-2-phenyl-ethyl)-amide

C17H24N2O3 (304.17868339999995)


   

Ethylaminobenzylmethylcarbonyl group

Ethylaminobenzylmethylcarbonyl group

C17H24N2O3 (304.17868339999995)


   

[(2R)-3-carboxy-2-[(3S)-5-carboxy-3-methylpentanoyl]oxypropyl]-trimethylazanium

[(2R)-3-carboxy-2-[(3S)-5-carboxy-3-methylpentanoyl]oxypropyl]-trimethylazanium

C14H26NO6+ (304.1760036)


   

[3-Carboxy-1-(6-carboxyhexanoyloxy)propyl]-trimethylazanium

[3-Carboxy-1-(6-carboxyhexanoyloxy)propyl]-trimethylazanium

C14H26NO6+ (304.1760036)


   

[(2R)-3-carboxy-2-(6-carboxyhexanoyloxy)propyl]-trimethylazanium

[(2R)-3-carboxy-2-(6-carboxyhexanoyloxy)propyl]-trimethylazanium

C14H26NO6+ (304.1760036)


   

[3-Carboxy-2-(4-carboxy-4-methylpentanoyl)oxypropyl]-trimethylazanium

[3-Carboxy-2-(4-carboxy-4-methylpentanoyl)oxypropyl]-trimethylazanium

C14H26NO6+ (304.1760036)


   

[3-Carboxy-2-(4-carboxyhexanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(4-carboxyhexanoyloxy)propyl]-trimethylazanium

C14H26NO6+ (304.1760036)


   

Indolo(2,3:3,4)pyrido(1,2-b)(2,7)naphthyridinium, 5,7,8,13,13b,14-hexahydro-5,6-dimethyl-, (5S,6R,13bS)-

Indolo(2,3:3,4)pyrido(1,2-b)(2,7)naphthyridinium, 5,7,8,13,13b,14-hexahydro-5,6-dimethyl-, (5S,6R,13bS)-

C20H22N3+ (304.1813632)


   
   

3-hydroxy-2-phenylpropanoic acid [(5S)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octan-3-yl] ester

3-hydroxy-2-phenylpropanoic acid [(5S)-8,8-dimethyl-8-azoniabicyclo[3.2.1]octan-3-yl] ester

C18H26NO3+ (304.19125859999997)


   

(2S)-3-methyl-2-[[oxo-(1,2,3,4-tetrahydronaphthalen-1-ylamino)methyl]amino]pentanoic acid

(2S)-3-methyl-2-[[oxo-(1,2,3,4-tetrahydronaphthalen-1-ylamino)methyl]amino]pentanoic acid

C17H24N2O3 (304.17868339999995)


   
   
   
   
   
   
   
   
   
   
   
   

[(1S)-3-carboxy-1-(6-carboxyhexanoyloxy)propyl]-trimethylazanium

[(1S)-3-carboxy-1-(6-carboxyhexanoyloxy)propyl]-trimethylazanium

C14H26NO6+ (304.1760036)


   

[3-Carboxy-2-(6-carboxyhexanoyloxy)propyl]-trimethylazanium

[3-Carboxy-2-(6-carboxyhexanoyloxy)propyl]-trimethylazanium

C14H26NO6+ (304.1760036)


   

DPCPX

8-Cyclopentyl-1,3-dipropylxanthine

C16H24N4O2 (304.18991639999996)


D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists DPCPX (PD 116948), a xanthine derivative, is a highly potent and selective Adenosine A1 receptor antagonist, with a Ki of 0.46 nM in 3H-CHA binding to A1 receptors in rat whole brain membranes[1][2][3].

   
   

16beta-Fluoroandrost-4-ene-3,17-dione

Androst-4-ene-3,17-dione, 16beta-fluoro-

C19H25FO2 (304.1838482)